GLP-1 / GIP dual receptor agonist
Tirzepatide
LY3298176
Approved
Tirzepatide is a once-weekly dual GIP and GLP-1 receptor agonist that delivers potent glucose lowering and weight reduction through dual-pathway synergy. Manufactured at our own peptide facility.
Specification
| CAS number | 2023788-19-2 |
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.5 g/mol |
| Purity | ≥ 98% |
| Appearance | White to off-white powder |
| Storage | -20 °C ± 5 °C |
| Solubility | Water / DMSO |
| Documentation | DMF + FDA EIR |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied; availability is subject to regulatory approval in the buyer's jurisdiction.